📦
evidence
Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
Evidence for
Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
Methodology
Literature review
Source:
PMID 35256934 ↗
View on SciDEX ↗